SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-009369
Filing Date
2016-11-04
Accepted
2016-11-04 16:13:10
Documents
49
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q imgn-20160930x10q.htm 10-Q 857796
2 EX-10.1 imgn-20160930ex101243b67.htm EX-10.1 1777962
3 EX-10.2 imgn-20160930ex10216cd5c.htm EX-10.2 34928
4 EX-31.1 imgn-20160930ex311f5128f.htm EX-31.1 11555
5 EX-31.2 imgn-20160930ex312a69b8b.htm EX-31.2 11597
6 EX-32 imgn-20160930xex32.htm EX-32 10321
  Complete submission text file 0001558370-16-009369.txt   6358364

Data Files

Seq Description Document Type Size
7 EX-101.INS imgn-20160930.xml EX-101.INS 884929
8 EX-101.SCH imgn-20160930.xsd EX-101.SCH 41623
9 EX-101.CAL imgn-20160930_cal.xml EX-101.CAL 41810
10 EX-101.DEF imgn-20160930_def.xml EX-101.DEF 151704
11 EX-101.LAB imgn-20160930_lab.xml EX-101.LAB 397606
12 EX-101.PRE imgn-20160930_pre.xml EX-101.PRE 281498
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
IMMUNOGEN INC (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-17999 | Film No.: 161975306
SIC: 2834 Pharmaceutical Preparations